Analysis finds savings with transradial access

03/31/2013 | CardiovascularBusiness.com

Percutaneous coronary intervention using the transradial approach reduces hospital costs by an average of $553 compared with the transfemoral route, largely due to shorter post-procedure hospital stays, according to an analysis published in the American Heart Journal. Low-, medium- and high-risk patients in the transradial group all experienced a lower rate of in-hospital bleeding complications than those who received transfemoral treatment, according to the study.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ